Page last updated: 2024-09-05

sb 203580 and zardaverine

sb 203580 has been researched along with zardaverine in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(zardaverine)
Trials
(zardaverine)
Recent Studies (post-2010) (zardaverine)
3,48941,13767222

Protein Interaction Comparison

ProteinTaxonomysb 203580 (IC50)zardaverine (IC50)
Chain A, Phosphodiesterase 4DHomo sapiens (human)0.16
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)0.39
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)0.39
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)0.39
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)0.39
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)0.39
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)0.39
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)0.39
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)0.39
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)0.39
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)0.39
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)0.39
Chain B, cAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)0.39
Chain A, cGMP-specific 3',5'-cyclic phosphodiesteraseHomo sapiens (human)0.39
Chain A, cGMP-specific 3',5'-cyclic phosphodiesteraseHomo sapiens (human)0.39
cGMP-dependent 3',5'-cyclic phosphodiesteraseHomo sapiens (human)0.764
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8AHomo sapiens (human)0.764
cGMP-specific 3',5'-cyclic phosphodiesteraseHomo sapiens (human)0.764
cAMP-specific 3',5'-cyclic phosphodiesterase 4D Rattus norvegicus (Norway rat)0.21
cAMP-specific 3',5'-cyclic phosphodiesterase 4CRattus norvegicus (Norway rat)0.21
cAMP-specific 3',5'-cyclic phosphodiesterase 4BRattus norvegicus (Norway rat)0.21
cAMP-specific 3',5'-cyclic phosphodiesterase 4AHomo sapiens (human)0.4723
cAMP-specific 3',5'-cyclic phosphodiesterase 4ARattus norvegicus (Norway rat)0.21
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1BHomo sapiens (human)0.94
cAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)0.8067
cAMP-specific 3',5'-cyclic phosphodiesterase 4CHomo sapiens (human)0.4723
cAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)0.6691
cGMP-inhibited 3',5'-cyclic phosphodiesterase BHomo sapiens (human)0.6811
cGMP-inhibited 3',5'-cyclic phosphodiesterase AHomo sapiens (human)0.4912
Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11AHomo sapiens (human)0.94
cAMP-specific 3',5'-cyclic phosphodiesterase 7BHomo sapiens (human)0.94
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10AHomo sapiens (human)0.94

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barlow, DJ; Ehrman, TM; Hylands, PJ1

Other Studies

1 other study(ies) available for sb 203580 and zardaverine

ArticleYear
In silico search for multi-target anti-inflammatories in Chinese herbs and formulas.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Anti-Inflammatory Agents; Crystallography, X-Ray; Cyclooxygenase 1; Cyclooxygenase 2; Databases, Factual; Drug Design; Drugs, Chinese Herbal; Enzyme Inhibitors; JNK Mitogen-Activated Protein Kinases; Medicine, Chinese Traditional; Models, Chemical; Models, Molecular; Molecular Conformation; p38 Mitogen-Activated Protein Kinases; Phosphodiesterase 4 Inhibitors; Structure-Activity Relationship

2010